ImmunityBio, Inc.
ImmunityBio, Inc. (IBRX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 87 transactions totaling $5.5M, demonstrating a bearish sentiment with -$4.9M in net insider flow. The most recent transaction on Feb 23, 2026 involved a sale of 165,000 shares valued at $1.7M.
IBRX Insider Activity Summary
Who Is Buying IBRX Stock?
No significant insider buying has been recorded for IBRX in the recent period.
Who Is Selling IBRX Stock?
No significant insider selling has been recorded for IBRX in the recent period.
Is ImmunityBio, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IBRX is bearish with an Insider Alignment Score of 6/100 and a net flow of -$4.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
IBRX Frequently Asked Questions
Understanding IBRX Insider Activity
Insider trading at ImmunityBio, Inc. (IBRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading IBRX stock, having executed 87 transactions in the past 90 days. The most active insider is Capital, Llc Nant (Executive), who has made 3 transactions totaling $103.4M.
Related Tools
Track ImmunityBio, Inc. Insider Activity
Get notified when executives and directors at IBRX file new Form 4 transactions